...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Free
Discussion Forum: Resverlogix Corp.
Message Title
Rating
Author / Date
1
Nov 11, 2019 03:57PM
1
Nov 11, 2019 03:33PM
2
Nov 11, 2019 03:18PM
3
Nov 11, 2019 02:26PM
2
Nov 11, 2019 12:36PM
3
Nov 11, 2019 12:25PM
2
Nov 11, 2019 10:52AM